Autosomal recessive carpotarsal osteolysis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2775
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal recessive carpotarsal osteolysis (also known as multicentric carpotarsal osteolysis with or without nephropathy, autosomal recessive type) is an extremely rare inherited skeletal disorder characterized by progressive destruction (osteolysis) of the carpal bones (wrist) and tarsal bones (ankle). The condition typically presents in childhood with pain, swelling, and progressive loss of function in the hands and feet as the small bones gradually dissolve and are resorbed. Affected individuals may develop significant disability due to the progressive nature of the bone destruction, which can also involve other skeletal sites. Some patients may develop additional features including nephropathy (kidney disease), which can progress to renal failure and significantly impact prognosis. The disease follows an autosomal recessive inheritance pattern, meaning that both copies of the responsible gene must carry a pathogenic variant for the condition to manifest. The exact genetic basis of the autosomal recessive form remains incompletely characterized, distinguishing it from the autosomal dominant form of multicentric osteolysis which has been linked to mutations in the MAFB gene. The skeletal and renal systems are the primary organ systems affected. Diagnosis is typically based on clinical findings and radiographic evidence of progressive osteolysis of the carpal and tarsal bones, combined with family history consistent with recessive inheritance. There is currently no curative treatment for autosomal recessive carpotarsal osteolysis. Management is supportive and symptomatic, focusing on pain control, physical and occupational therapy to maintain function, orthopedic interventions as needed, and monitoring of renal function. In cases where nephropathy progresses to end-stage renal disease, dialysis or kidney transplantation may be required. Given the extreme rarity of this condition, management is best coordinated through multidisciplinary teams at centers experienced in rare skeletal disorders.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal recessive carpotarsal osteolysis.

View clinical trials →

No actively recruiting trials found for Autosomal recessive carpotarsal osteolysis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal recessive carpotarsal osteolysis community →

No specialists are currently listed for Autosomal recessive carpotarsal osteolysis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal recessive carpotarsal osteolysis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal recessive carpotarsal osteolysisForum →

No community posts yet. Be the first to share your experience with Autosomal recessive carpotarsal osteolysis.

Start the conversation →

Latest news about Autosomal recessive carpotarsal osteolysis

No recent news articles for Autosomal recessive carpotarsal osteolysis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autosomal recessive carpotarsal osteolysis

What is Autosomal recessive carpotarsal osteolysis?

Autosomal recessive carpotarsal osteolysis (also known as multicentric carpotarsal osteolysis with or without nephropathy, autosomal recessive type) is an extremely rare inherited skeletal disorder characterized by progressive destruction (osteolysis) of the carpal bones (wrist) and tarsal bones (ankle). The condition typically presents in childhood with pain, swelling, and progressive loss of function in the hands and feet as the small bones gradually dissolve and are resorbed. Affected individuals may develop significant disability due to the progressive nature of the bone destruction, which

How is Autosomal recessive carpotarsal osteolysis inherited?

Autosomal recessive carpotarsal osteolysis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal recessive carpotarsal osteolysis typically begin?

Typical onset of Autosomal recessive carpotarsal osteolysis is childhood. Age of onset can vary across affected individuals.